Cargando…
P1469: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FOLLOWING 9-WEEK OFF-TREATMENT PERIOD (WASHOUT) IN THE PHASE 3 CADENZA STUDY
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429917/ http://dx.doi.org/10.1097/01.HS9.0000972760.33312.35 |
_version_ | 1785090830803927040 |
---|---|
author | Röth, Alexander Berentsen, Sigbjørn Barcellini, Wilma D’sa, Shirley Jilma, Bernd Michel, Marc Weitz, Ilene C Yamaguchi, Masaki Nishimura, Jun-Ichi Vos, Josephine Cid, Joan Storek, Michael Wong, Nancy Yoo, Ronnie Jayawardene, Deepthi Kralova, Katarina Wardęcki, Marek Shafer, Frank Lee, Michelle Broome, Catherine M |
author_facet | Röth, Alexander Berentsen, Sigbjørn Barcellini, Wilma D’sa, Shirley Jilma, Bernd Michel, Marc Weitz, Ilene C Yamaguchi, Masaki Nishimura, Jun-Ichi Vos, Josephine Cid, Joan Storek, Michael Wong, Nancy Yoo, Ronnie Jayawardene, Deepthi Kralova, Katarina Wardęcki, Marek Shafer, Frank Lee, Michelle Broome, Catherine M |
author_sort | Röth, Alexander |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10429917 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104299172023-08-17 P1469: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FOLLOWING 9-WEEK OFF-TREATMENT PERIOD (WASHOUT) IN THE PHASE 3 CADENZA STUDY Röth, Alexander Berentsen, Sigbjørn Barcellini, Wilma D’sa, Shirley Jilma, Bernd Michel, Marc Weitz, Ilene C Yamaguchi, Masaki Nishimura, Jun-Ichi Vos, Josephine Cid, Joan Storek, Michael Wong, Nancy Yoo, Ronnie Jayawardene, Deepthi Kralova, Katarina Wardęcki, Marek Shafer, Frank Lee, Michelle Broome, Catherine M Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429917/ http://dx.doi.org/10.1097/01.HS9.0000972760.33312.35 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Röth, Alexander Berentsen, Sigbjørn Barcellini, Wilma D’sa, Shirley Jilma, Bernd Michel, Marc Weitz, Ilene C Yamaguchi, Masaki Nishimura, Jun-Ichi Vos, Josephine Cid, Joan Storek, Michael Wong, Nancy Yoo, Ronnie Jayawardene, Deepthi Kralova, Katarina Wardęcki, Marek Shafer, Frank Lee, Michelle Broome, Catherine M P1469: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FOLLOWING 9-WEEK OFF-TREATMENT PERIOD (WASHOUT) IN THE PHASE 3 CADENZA STUDY |
title | P1469: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FOLLOWING 9-WEEK OFF-TREATMENT PERIOD (WASHOUT) IN THE PHASE 3 CADENZA STUDY |
title_full | P1469: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FOLLOWING 9-WEEK OFF-TREATMENT PERIOD (WASHOUT) IN THE PHASE 3 CADENZA STUDY |
title_fullStr | P1469: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FOLLOWING 9-WEEK OFF-TREATMENT PERIOD (WASHOUT) IN THE PHASE 3 CADENZA STUDY |
title_full_unstemmed | P1469: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FOLLOWING 9-WEEK OFF-TREATMENT PERIOD (WASHOUT) IN THE PHASE 3 CADENZA STUDY |
title_short | P1469: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FOLLOWING 9-WEEK OFF-TREATMENT PERIOD (WASHOUT) IN THE PHASE 3 CADENZA STUDY |
title_sort | p1469: inhibition of complement c1s with sutimlimab in patients with cold agglutinin disease (cad): results following 9-week off-treatment period (washout) in the phase 3 cadenza study |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429917/ http://dx.doi.org/10.1097/01.HS9.0000972760.33312.35 |
work_keys_str_mv | AT rothalexander p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy AT berentsensigbjørn p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy AT barcelliniwilma p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy AT dsashirley p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy AT jilmabernd p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy AT michelmarc p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy AT weitzilenec p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy AT yamaguchimasaki p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy AT nishimurajunichi p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy AT vosjosephine p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy AT cidjoan p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy AT storekmichael p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy AT wongnancy p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy AT yooronnie p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy AT jayawardenedeepthi p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy AT kralovakatarina p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy AT wardeckimarek p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy AT shaferfrank p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy AT leemichelle p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy AT broomecatherinem p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy |